Discounted Cash Flow
Elevance Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $84.9b | $2.5b | $2.6b | 2.9% | $9.39 |
| 2017 | $90.0b (6.1%) | $3.8b (55.6%) | $3.4b (29.2%) | 4.3% (46.6%) | $14.70 (56.5%) |
| 2018 | $92.1b (2.3%) | $3.8b (-2.4%) | $2.6b (-22.6%) | 4.1% (-4.6%) | $14.53 (-1.2%) |
| 2019 | $104.2b (13.1%) | $4.8b (28.2%) | $5.0b (90.3%) | 4.6% (13.3%) | $18.81 (29.5%) |
| 2020 | $121.9b (16.9%) | $4.6b (-4.9%) | $-8.8b (-276.6%) | 3.8% (-18.7%) | $18.23 (-3.1%) |
| 2021 | $138.6b (13.8%) | $6.1b (33.5%) | $-10.3b (-17.0%) | 4.4% (17.4%) | $25.04 (37.4%) |
| 2022 | $156.6b (13.0%) | $6.0b (-1.3%) | $-16.5b (-60.6%) | 3.8% (-12.6%) | $25.10 (0.2%) |
| 2023 | $171.3b (9.4%) | $6.0b (-0.6%) | $-8.2b (50.6%) | 3.5% (-9.2%) | $25.38 (1.1%) |
| 2024 | $177.0b (3.3%) | $6.0b (-0.1%) | $-12.2b (-49.0%) | 3.4% (-3.3%) | $25.81 (1.7%) |
| 2025 | $199.1b (12.5%) | $5.7b (-5.3%) | $-10.7b (11.8%) | 2.8% (-15.8%) | $25.28 (-2.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.